Provivi discloses $3m in equity financing
The crop-protection company reported $3,022,267 sold in an offering targeting approximately $25m.
Provivi disclosed $3,022,267 in equity financing in a Form D filed on November 3, 2026. The filing reports one investor and a first sale on October 28. The offering’s total target is $25,000,056.
The Santa Monica company develops pheromone-based crop protection. Its products interfere with pest mating and reproduction, giving farmers a preventive way to manage insects that damage crops such as corn and rice.